rs562882648
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001134363.3(RBM20):c.2547T>A(p.Asn849Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000283 in 1,448,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N849H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1DDInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBM20 | NM_001134363.3 | c.2547T>A | p.Asn849Lys | missense_variant | Exon 9 of 14 | ENST00000369519.4 | NP_001127835.2 | |
| RBM20 | XM_017016103.3 | c.2382T>A | p.Asn794Lys | missense_variant | Exon 9 of 14 | XP_016871592.1 | ||
| RBM20 | XM_017016104.3 | c.2163T>A | p.Asn721Lys | missense_variant | Exon 9 of 14 | XP_016871593.1 | ||
| RBM20 | XM_047425116.1 | c.2163T>A | p.Asn721Lys | missense_variant | Exon 9 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152024Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000497 AC: 4AN: 80464 AF XY: 0.0000255 show subpopulations
GnomAD4 exome AF: 0.0000108 AC: 14AN: 1295998Hom.: 0 Cov.: 30 AF XY: 0.00000957 AC XY: 6AN XY: 627182 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000177 AC: 27AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: RBM20 c.2547T>A (p.Asn849Lys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5e-05 in 80464 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2547T>A has been reported in at-least one individual from the Percutaneous Stem Cell Injection Delivery Effects On Neomyogenesisin Dilated Cardiomyopathy trial (POSEIDON-DCM; NCT01392625) and authors classified the variant as VUS (Rieger_2019). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014and classified the variant as likely benign, and as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31648988) -
Cardiovascular phenotype Uncertain:1
The p.N849K variant (also known as c.2547T>A), located in coding exon 9 of the RBM20 gene, results from a T to A substitution at nucleotide position 2547. The asparagine at codon 849 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1DD Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at